Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Sysco
SYY
$40B
| $37M | 0.03% |
676,335
-749,265
| -53% | -$39.4M |
|
527
Las Vegas Sands
LVS
$29.6B
| $36.9M | 0.03% |
+810,800
| New | +$38.1M |
|
|
BBBY
528
Bed Bath & Beyond
BBBY
$423M
| $36.7M | 0.03% |
+1,420,870
| New | +$20.9M |
|
529
UGI
UGI
$7.56B
| $36.7M | 0.03% |
1,153,845
-1,222,664
| -51% | -$37.1M |
|
530
Ennis
EBF
$559M
| $36.7M | 0.03% |
2,022,182
+111,200
| +6% | +$1.96M |
|
|
IMOS
531
ChipMOS TECHNOLOGIES
IMOS
$2.01B
| $36.7M | 0.03% |
1,617,900
+30,600
| +2% | +$627K |
|
|
SRDX
532
DELISTED
Surmodics
SRDX
| $36.4M | 0.03% |
842,600
-15,600
| -2% | -$590K |
|
533
TechTarget
TTGT
$277M
| $36.4M | 0.03% |
1,213,200
+177,500
| +17% | +$4.48M |
|
534
Live Nation Entertainment
LYV
$43.3B
| $36.2M | 0.03% |
+816,866
| New | +$35.8M |
|
535
Invitation Homes
INVH
$18B
| $36.1M | 0.03% |
1,311,621
-6,185,283
| -83% | -$155M |
|
|
DOOR
536
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $36.1M | 0.03% |
463,600
-74,300
| -14% | -$4.51M |
|
537
Lamar Advertising Co
LAMR
$15.8B
| $35.8M | 0.03% |
536,542
-1,142,618
| -68% | -$69.8M |
|
538
Tower Semiconductor
TSEM
$28.6B
| $35.8M | 0.03% |
1,873,386
-111,500
| -6% | -$2.13M |
|
539
Banco de Chile
BCH
$20.5B
| $35.7M | 0.03% |
2,024,454
+44,200
| +2% | +$777K |
|
540
Melco Resorts & Entertainment
MLCO
$2.14B
| $35.5M | 0.03% |
2,289,665
-1,475,300
| -39% | -$22.8M |
|
541
e.l.f. Beauty
ELF
$5.43B
| $35.5M | 0.03% |
1,861,600
+393,600
| +27% | +$5.63M |
|
|
CHU
542
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $35.5M | 0.03% |
6,506,335
+653,965
| +11% | +$3.98M |
|
|
SVM
543
Silvercorp Metals
SVM
$2.61B
| $35.4M | 0.03% |
6,584,996
-879,699
| -12% | -$3.7M |
|
544
Advanced Drainage Systems
WMS
$11.3B
| $35.3M | 0.03% |
715,037
+61,100
| +9% | +$2.51M |
|
545
Sherwin-Williams
SHW
$87.8B
| $35.3M | 0.03% |
+183,300
| New | +$33M |
|
546
Ormat Technologies
ORA
$6.98B
| $35.3M | 0.03% |
555,357
-171,343
| -24% | -$11.2M |
|
|
RDFN
547
DELISTED
Redfin
RDFN
| $35.2M | 0.03% |
841,000
-267,400
| -24% | -$7.04M |
|
548
Targa Resources
TRGP
$57.2B
| $35M | 0.03% |
1,743,492
-394,794
| -18% | -$5.94M |
|
549
Grocery Outlet
GO
$1.07B
| $34.9M | 0.03% |
854,300
+535,400
| +168% | +$19.2M |
|
550
Bath & Body Works
BBWI
$3.76B
| $34.6M | 0.03% |
+2,861,840
| New | +$31.9M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.